The FDA cleared VisuALIF is a two-piece, stand alone device, modular lumbar interbody device with an open-face allowing in situ graft placement, tactile feedback with face plate attachment and device placement flush with the anterior aspect of the vertebrae.

SpineSmith said the device is available in a range of product sizes and configurations designed to meet surgeon requirements across a wide spectrum of patient anatomy.

SpineSmith vice president of Engineering Brian Burkinshaw said the VisuALIF offers a solution for surgeons and it incorporates an anterior open-face, allowing surgeons to visualize end plate preparation post-placement, leading to optimum graft placement with respect to larger available volumes.

"During our alpha launch we received positive feedback regarding the implant and have fine-tuned our instrumentation to create a best in class system relative to surgeon ease of use," Burkinshaw said.